ROCHESTER, N.Y. — Kodak is expanding its pharmaceutical offerings with the introduction of four new products. These products are variations of “phosphate buffered saline” and “water for injection,” which are essential ingredients for laboratory research.
Kodak is working to offer more pharmaceuticals in the future.
“The expansion of Kodak’s existing unregulated key starting materials business to include high-quality, reliable Class 1 regulated laboratory reagents is a milestone in our long-term plan,” said Jim Continenza, Kodak’s Executive Chairman and CEO.
For more information, visit Kodak’s website here.
Kodak expands pharmaceutical portfolio by introducing four new products WHEC.com.
Hence then, the article about kodak expands pharmaceutical portfolio by introducing four new products was published today ( ) and is available on News10NBC ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( Kodak expands pharmaceutical portfolio by introducing four new products )
Also on site :
- 20 Years Later, This 2000s Emo Band Remains 'One of the Most Significant Rock Bands' Amid Sold-Out Tour
- Wide-Leg Capri Pants Are a Summer 2026 Wardrobe Staple, and You Can Snag a Pair for Just $10 at Amazon
- ‘Independent Lens’ Series Acquires Four Documentaries: Prize Winners ‘Jane Elliott Against The World,’ ‘Seeds’ & More